CorMedix: HC Wainwright Maintains Buy Rating, PT Down to $13.

viernes, 23 de enero de 2026, 7:03 am ET1 min de lectura
CRMD--

CorMedix: HC Wainwright Maintains Buy Rating, PT Down to $13.

CorMedix: HC Wainwright Maintains Buy Rating, PT Down to $13.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios